Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

No-deal Brexit fears over medicine supplies prompt Dutch scramble for 50 'critical' UK-supplied drugs

Names of at-risk medicines kept secret by Netherlands' Bruno Bruins to prevent other EU states stockpiling and driving up costs

Alex Matthews-King
Health Correspondent
Friday 08 February 2019 11:18 EST
Comments
Bruno Bruins (right) has warned Brexit could leave the Netherlands without 'critical' drugs
Bruno Bruins (right) has warned Brexit could leave the Netherlands without 'critical' drugs (AP)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Dutch health officials are rushing to ensure “critical” drugs supplied by Britain are still available if the UK crashes out of the European Union without a deal next month.

The Netherlands’ health minister Bruno Bruins said that 50 drugs had been shortlisted from 2,700 UK-related medications because there are “no or no adequate alternatives on the Dutch market”.

However, he declined to release the names of the medications over fears that other EU states could hoard the drugs or drive up prices.

“Naming the medicines could lead to stockpiling – also in other EU countries,” he said in a letter to the Dutch parliament ahead of a debate on Brexit preparations on Thursday evening.

“Because this also involves medicines for which few or no alternatives exist, it could lead to speculation [on products’ availability].”

This is the latest sign of the problems that Theresa May’s chaotic Brexit negotiations are causing EU states and comes after Dutch hospitals warned lives were at risk in the event of a no-deal Brexit.

A spokesperson for Mr Bruins from the Dutch Health Ministry told The Independent they were working with pharmacists and wholesalers to find alternative suppliers for these drugs.

The Netherlands is among the countries most vulnerable if Brexit increases customs friction with Britain, though Amsterdam recently became the new home of the European Medicines Agency after it was forced to leave London.

In the UK, stalled negotiations have led to NHS-wide contingency measures being triggered, with health chiefs touring hospitals to assess preparations for disruption to staff, medical supplies and basic essentials like food.

Health secretary Matt Hancock has ordered drug companies to build up six-week supplies of medicines, but has triggered plans to airlift in key supplies in the event of six months of Brexit gridlock at ferry ports.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in